Rab8 binding to immune cell-specific adaptor LAX facilitates formation of trans-golgi network-proximal CTLA-4 vesicles for surface expression

Molecular and Cellular Biology

Volumn 34, Issue 8, 2014, Pages 1486-1499

  Banton, Matthew C ^a   Inder, Kerry L ^a,c   Valk, Elke ^a,d   Rudd, Christopher E ^a,b   Schneider, Helga ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; LAX PROTEIN; RAB PROTEIN; RAB8 PROTEIN; SMALL INTERFERING RNA; T LYMPHOCYTE RECEPTOR; TRIM PROTEIN; TUBULIN; UNCLASSIFIED DRUG; GERMINAL CENTER KINASES; LAX1 PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; INTRACELLULAR TRANSPORT; MICROTUBULE ORGANIZING CENTER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; T LYMPHOCYTE ACTIVATION; TRANS GOLGI NETWORK; WILD TYPE; ANIMAL; CELL LINE; CELL MEMBRANE; CULTURE TECHNIQUE; IMMUNOLOGY; METABOLISM; MOUSE; T LYMPHOCYTE;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; CELL MEMBRANE; CTLA-4 ANTIGEN; HUMANS; MICE; MONOMERIC GTP-BINDING PROTEINS; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANS-GOLGI NETWORK;

EID: 84896512664     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01331-13     Document Type: Article

References (63)

1. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547. http://dx.doi.org/10.1016/1074-7613(95)90125-6.
2. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270: 985-988. http://dx.doi.org/10.1126/science.270.5238.985.
3. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne-Smyth FD, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers JJ, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511. http://dx.doi.org/10.1038/nature01621.
4. Schneider H, Smith X, Liu H, Bismuth G, Rudd CE. 2008. CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization. Eur. J. Immunol. 38:40-47. http://dx.doi.org/10.1002/eji.200737423.
5. Pentcheva-Hoang T, Egen JG, Wojnoonski K, Allison JP. 2004. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 21:401-413. http://dx.doi.org/10.1016/j.immuni.2004.06.017.
6. Chuang E, Fisher TS, Morgan RW, Robbins MD, Duerr JM, Vander Heiden MG, Gardner JP, Hambor JE, Neveu MJ, Thompson CB. 2000. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 13:313-322. http://dx.doi.org/10.1016/S1074-7613(00)00031-5.
7. Marengère LEM, Waterhouse P, Duncan GS, Mittrücker HW, Feng GS, Mak TW. 1996. Regulation of T cell receptor signaling by tyrosine phosphatase Syp association with CTLA-4. Science 272:1170-1173. http://dx.doi.org/10.1126/science.272.5265.1170.
8. Masteller EL, Chuang E, Mullen AC, Reiner SL, Thompson CB. 2000. Structural analysis of CTLA-4 function in vivo. J. Immunol. 164:5319-5327.
9. Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, Baker J, Jeffery LE, Kaur S, Briggs Z, Hou TZ, Futter CE, Anderson G, Walker LS, Sansom DM. 2011. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332: 600-603. http://dx.doi.org/10.1126/science.1202947.
10. Boasso A, Herbeuval JP, Hardy AW, Winkler C, Shearer GM. 2005. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNAsynthetase by CTLA-4-Fc in human CD4 T cells. Blood 105:1574-1581. http://dx.doi.org/10.1182/blood-2004-06-2089.
11. Oida T, Xu L, Weiner HL, Kitani A, Strober W. 2006. TGF-β-mediated suppression by CD4 CD25 T cells is facilitated by CTLA-4 signaling. J. Immunol. 177:2331-2339.
12. Schneider H, Valk E, da Rocha Dias S, Wei B, Rudd CE. 2005. CTLA-4 upregulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function. Proc. Natl. Acad. Sci. U. S. A. 102:12861-12866. http://dx.doi.org/10.1073/pnas.0505802102.
13. Schneider H, Downey J, Smith A, Zinselmeyer BH, Rush C, Brewer JM, Wei B, Hogg N, Garside P, Rudd CE. 2006. Reversal of the TCR stop signal by CTLA-4. Science 313:1972-1975. http://dx.doi.org/10.1126/science.1131078.
14. Rudd CE. 2008. The reverse stop-signal model for CTLA4 function. Nat. Rev. Immunol. 8:153-160. http://dx.doi.org/10.1038/nri2253.
15. Mustelin T. 2006. Immunology Restless T cells sniffand go. Science 313: 1902-1903. http://dx.doi.org/10.1126/science.1133578.
16. Hara S, Nakaseko C, Yamasaki S, Hattori M, Bos JL, Saito Y, Minato N, Saito T. 2009. Involvement of Rap-1 activation and early termination of immune synapse in CTLA-4-mediated negative signal. Hematology 14: 150-158. http://dx.doi.org/10.1179/102453309X402241.
17. Knieke K, HoffH, Maszyna F, Kolar P, Schrage A, Hamann AA, Debes GF, Brunner-Weinzierl MC. 2009. CD152 (CTLA-4) determines CD4 T cell migration in vitro and in vivo. PLoS One 4:e5702. http://dx.doi.org/10.1371/journal.pone.0005702.
18. Ruocco MG, Pilones KA, Kawashima N, Cammer M, Huang J, Babb JS, Liu MM, Formenti SC, Dustin ML, Demaria S. 2012. Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects. J. Clin. Invest. 122:3718-3730. http://dx.doi.org/10.1172/JCI61931.
19. Leung HT, Bradshaw J, Cleaveland JS, Linsley PS. 1995. Cytotoxic T lymphocyte-associated molecule-4, a high avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J. Biol. Chem. 270:25107-25114. http://dx.doi.org/10.1074/jbc.270.42.25107.
20. Schneider H, Martin M, Agarraberes FA, Yin L, Rapoport I, Kirchhausen T, Rudd CE. 1999. Cytolytic T lymphocyte-associated antigen-4 and the TcRz/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2. J. Immunol. 163:1868-1879.
21. Iida T, Ohno H, Nakaseko C, Sakuma M, Takeda-Ezaki M, Arase H, Kominami E, Fujisawa T, Saito T. 2000. Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4 T cells. J. Immunol. 165:5062-5068.
22. Valk E, Leung R, Kang H, Kaneko K, Rudd CE, Schneider H. 2006. H. Schneider, T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor. Immunity 25: 807-821. http://dx.doi.org/10.1016/j.immuni.2006.08.024.
23. Linsley PS, Bradshaw J, Greene J, Peach R, Bennet KL, Mittler RS. 1996. Intracellular trafficking of CTLA-4 and focal localization toward sites of TCR engagement. Immunity 4:535-543. http://dx.doi.org/10.1016/S1074-7613(00)80480-X.
24. Barrat FJ, Le Deist F, Benkerrou M, Bousso P, Feldmann J, Fischer A, de Saint Basile G. 1999. Defective CTLA-4 cycling pathway in Chediak- Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation. Proc. Natl. Acad. Sci. U. S. A. 96:8645-8650. http://dx.doi.org/10.1073/pnas.96.15.8645.
25. Valk E, Rudd CE, Schneider H. 2008. CTLA-4 trafficking and surface expression. Trends Immunol. 29:272-279. http://dx.doi.org/10.1016/j.it.2008.02.011.
26. Schneider H, Prasad KVS, Shoelson SE, Rudd CE. 1995. CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med. 181:351-355. http://dx.doi.org/10.1084/jem.181.1.351.
27. Bradshaw JD, Lu P, Leytze G, Rodgers J, Schieven GL, Bennett KL, Linsley PS, Kurtz SE. 1997. Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation. Biochemistry 36:15975-15982. http://dx.doi.org/10.1021/bi971762i.
28. Shiratori T, Miyatake S, Ohno H, Nakaseko C, Isono K, Bonifacino JS, Saito TT. 1997. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 6:583-589. http://dx.doi.org/10.1016/S1074-7613(00)80346-5.
29. Zhang Y, Allison JP. 1997. Interaction of CTLA-4 with AP-50, a clathrincoated pit adaptor protein. Proc. Natl. Acad. Sci. U. S. A. 94:9273-9278. http://dx.doi.org/10.1073/pnas.94.17.9273.
30. Chuang E, Alègre ML, Duckett CS, Noel PJ, Vander Heiden MG, Thompson CB. 1997. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 159:144-151.
31. Rudd CE, Taylor A, Schneider H. 2009. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol. Rev. 229:12-26. http://dx.doi.org/10.1111/j.1600-065X.2009.00770.x.
32. Kliche S, Lindquist JA, Schraven B. 2004. Transmembrane adapters: structure, biochemistry, and biology. Semin. Immunol. 16:367-377. http://dx.doi.org/10.1016/j.smim.2004.08.017.
33. Blumberg RS, Alarcon B, Sancho J, McDermott FV, Lopez P, Breitmeyer J, Terhorst C. 1990. Assembly and function of the T cell antigen receptor: requirement of either the lysine or arginine residues in the transmembrane region of the alpha chain. J. Biol. Chem. 265:14036-14043.
34. Kölsch U, Arndt B, Reinhold D, Lindquist JA, Juling N, Kliche S, Pfeffer K, Bruyns E, Schraven B, Simeoni L. 2006. Normal T-cell development and immune functions in TRIM-deficient mice. Mol. Cell. Biol. 26:3639-3648. http://dx.doi.org/10.1128/MCB.26.9.3639-3648.2006.
35. Simeoni L, Posevitz V, Kölsch U, Meinert I, Bruyns E, Pfeffer K, Reinhold D, Schraven B. 2005. The transmembrane adapter protein SIT regulates thymic development and peripheral T-cell functions. Mol. Cell. Biol. 25:7557-7568. http://dx.doi.org/10.1128/MCB.25.17.7557-7568.2005.
36. Zhu M, Granillo O, Wen R, Yang K, Dai X, Wang D, Zhang W. 2005. Negative regulation of lymphocyte activation by the adaptor protein LAX. J. Immunol. 174:5612-5619.
37. Nobes CD, Hall A. 1999. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 144:1235-1244. http://dx.doi.org/10.1083/jcb.144.6.1235.
38. Pfeffer S, Aivazian D. 2004. Targeting Rab GTPases to distinct membrane compartments. Nat. Rev. Mol. Cell. Biol. 5:886-896. http://dx.doi.org/10.1038/nrm1500.
39. Stenmark H. 2009. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell. Biol. 10:513-525. http://dx.doi.org/10.1038/nrm2728.
40. Christoforidis S, Miaczynska M, Ashman K, Wilm M, Zhao L, Yip SC, Waterfield MD, Backer JM, Zerial M. 1999. Phosphatidylinositol-3-OH kinases are Rab5 effectors. Nat. Cell Biol. 1:249-252. http://dx.doi.org/10.1038/12075.
41. Stenmark H, Bucci C, Zerial M. 1995. Expression of Rab GTPases using recombinant vaccinia viruses. Methods Enzymol. 257:155-164. http://dx.doi.org/10.1016/S0076-6879(95)57021-7.
42. Horiuchi H, Lippe R, McBride HM, Rubino M, Woodman P, Stenmark H, Rybin V, Wilm M, Ashman K, Mann M, Zerial M. 1997. A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function. Cell 90:1149-1159. http://dx.doi.org/10.1016/S0092-8674(00)80380-3.
43. Nielsen E, Christoforidis S, Uttenweiler-Joseph S, Miaczynska M, Dewitte F, Wilm M, Hoflack B, Zerial M. 2000. Rabenosyn-5, a novel Rab5 effector, is complexed with hVPS45 and recruited to endosomes through a FYVE finger domain. J. Cell Biol. 151:601-612. http://dx.doi.org/10.1083/jcb.151.3.601.
44. Hattula K, Furuhjelm J, Tikkanen J, Tanhuanpaa K, Laakkonen P, Peränen J. 2006. Characterization of the Rab8-specific membrane traffic route linked to protrusion formation. J. Cell Sci. 119:4866-4877. http://dx.doi.org/10.1242/jcs.03275.
45. Ang AL, Folsch H, Koivisto UM, Pypaert M, Mellman I. 2003. The Rab8 GTPase selectively regulates AP-1B-dependent basolateral transport in polarized Madin-Darby canine kidney cells. J. Cell Biol. 163:339-350. http://dx.doi.org/10.1083/jcb.200307046.
46. Stenmark H, Olkkonen VM. 2001. The Rab GTPase family. Genome Biol. 2:REVIEWS3007. http://dx.doi.org/10.1186/gb-2001-2-5-reviews3007.
47. Rodriguez OC, Cheney RE. 2002. Human myosin-Vc is a novel class V myosin expressed in epithelial cells. J. Cell Sci. 115:991-1004.
48. Peränen J, Auvinen P, Virta H, Wepf R, Simons K. 1996. Rab8 promotes polarized membrane transport through reorganization of actin and microtubules in fibroblasts. J. Cell Biol. 135:153-167. http://dx.doi.org/10.1083/jcb.135.1.153.
49. Peränen J, Furuhjelm J. 2001. Expression, purification, and properties of Rab8 function in actin cortical skeleton organization and polarized transport. Methods Enzymol. 329:188-196. http://dx.doi.org/10.1016/S0076-6879(01)29079-X.
50. Nagabhushana A, Chalasani ML, Jain N, Radha V, Rangaraj N, Balasubramanian D, Swarup G. 2010. Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucomaassociated mutant. BMC Cell Biol. 11:4. http://dx.doi.org/10.1186/1471-2121-11-4.
51. Roland JT, Kenworthy AK, Peränen J, Caplan S, Goldenring JR. 2007. Myosin Vb interacts with Rab8a on a tubular network containing EHD1 and EHD3. Mol. Biol. Cell 18:2828-2837. http://dx.doi.org/10.1091/mbc. E07-02-0169.
52. Ren M, Zeng J, De Lemos-Chiarandini C, Rosenfeld M, Adesnik M, Sabatini DD. 1996. In its active form, the GTP-binding protein rab8 interacts with a stress-activated protein kinase. Proc. Natl. Acad. Sci. U. S. A. 93:5151-5155. http://dx.doi.org/10.1073/pnas.93.10.5151.
53. Hattula K, Peränen J. 2000. FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis. Curr. Biol. 10:1603-1606. http://dx.doi.org/10.1016/S0960-9822(00)00864-2.
54. Dong C, Yang L, Zhang X, Gu H, Lam ML, Claycomb WCWC, Xia H, Wu G. 2010. Rab8 interacts with distinct motifs in α2B- and β2-adrenergic receptors and differentially modulates their transport. J. Biol. Chem. 285:20369-20380. http://dx.doi.org/10.1074/jbc. M109.081521.
55. Zerial M, Mcbride H. 2001. Rab proteins as membrane organizers. Nat. Rev. Mol. Cell. Biol. 2:107-117. http://dx.doi.org/10.1038/35052055.
56. Egen JG, Allison JP. 2002. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16:23-35. http://dx.doi.org/10.1016/S1074-7613(01)00259-X.
57. Chi ZL, Akahori M, Obazawa M, Minami M, Noda T, Nakaya N, Tomarev S, Kawase K, Yamamoto T, Noda S, Sasaoka M, Shimazaki AA, Takada Y, Iwata T. 2010. Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Hum. Mol. Genet. 19:2606-2615. http://dx.doi.org/10.1093/hmg/ddq146.
58. Wolchok JD, Hodi FS, Weber JS, Allison JP, Urba WJ, Robert C, O'Day SJ, Hoos AA, Humphrey R, Berman DM, Lonberg N, Korman AJ. 2013. Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma. Ann. N. Y. Acad. Sci. 1291:1-13. http://dx.doi.org/10.1111/nyas.12180.
59. Simonsen A, Lippe R, Christoforidis S, Gaullier JM, Brech A, Callaghan J, Toh BH, Murphy C, Zerial M, Stenmark H. 1998. EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature 394:494-498. http://dx.doi.org/10.1038/28879.
60. Jean S, Kiger AA. 2012. Coordination between RAB GTPase and phosphoinositide regulation and functions. Nat. Rev. Mol. Cell. Biol. 13:463-470. http://dx.doi.org/10.1038/nrm3379.
61. Honda A, Nogami M, Yokozeki T, Yamazaki M, Nakamura H, Watanabe H, Kawamoto K, Nakayama K, Morris AJ, Frohman MA, Kanaho Y. 1999. Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation. Cell 99:521-532. http://dx.doi.org/10.1016/S0092-8674(00) 81540-8.
62. Shin HW, Hayashi M, Christoforidis S, Lacas-Gervais S, Hoepfner S, Wenk MR, Modregger J, Uttenweiler-Joseph S, Wilm M, Nystuen A, Frankel WN, Solimena M, De Camilli P, Zerial M. 2005. An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. J. Cell Biol. 170:607-618. http://dx.doi.org/10.1083/jcb.200505128.
63. Chapgar RB, Links PH, Pastor MC, Furber LA, Hawrysh AD, Chamberlain MD, Anderson DH. 2010. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U. S. A. 107:5471-5476. http://dx.doi.org/10.1073/pnas.0908899107.